AbCellera's Surges on Antibody Collaboration with Biogen
Monday, 11 March 2024, 16:23
AbCellera Collaborates with Biogen
AbCellera Biologics experiences a 3% surge following the announcement of a collaboration with Biogen to develop neurological antibodies.
Potential Impact on Neurological Treatments
This partnership holds significant promise for advancing treatments in neurology with innovative antibody solutions from AbCellera and Biogen.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.